Dr Anji Anand
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Oncology_Head_shot_GA_Anji_Anand.jpg

Dr Anji Anand

Dr Anji Anand
Anji
Anand
MB, ChB, FRCR, Clinical oncologist

Languages spoken

English

Expert in

Breast cancer, Genitourinary cancer, Gynaecological cancer

Overview

Centres

Specialises in

Breast cancer
Condition
Condition/Cancer
Condition/Cancer/Breast cancer
Genitourinary cancer
Condition
Condition/Cancer
Condition/Cancer/Genitourinary cancer
Gynaecological cancer
Condition
Condition/Cancer
Condition/Cancer/Gynaecological cancer

Treatments

Chemotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Chemotherapy
Intensity modulated radiotherapy (IMRT)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Intensity modulated radiotherapy
Radiotheraphy
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Radiotherapy

Dr Anand is a Consultant Clinical Oncologist with a specialist interest in the treatment of gynaecological and breast cancers.

Dr Anand is currently working as a Consultant Clinical Oncologist at Nottingham University Hospitals NHS trust. She has been in this post since 2010. Prior to her appointment as a consultant she trained as specialist registrar at Nottingham University Hospitals, Derby Royal Infirmary and University Hospitals of Leicester. Her special interests are gynaecological cancers and breast cancers.

She is the Lead Clinician instrumental in the development of HDR intracavitary brachytherapy for cervical and uterine cancers. In addition, she also treats ovarian cancer and has a special interest in the use of PARP inhibitors. She also treats patients with breast cancer using appropriate modalities of treatment- chemotherapy, adjuvant and palliative radiotherapy and endocrine treatment.

Career Positions

Current position(s)

  • Consultant Clinical Oncologist at Nottingham University Hospitals NHS trust

Expertise and interests

Expertise

  • Breast cancer and gynaecological cancer
  • Genitourinary cancer

Interests

  • Radiotherapy
  • Chemotherapy
  • Hormonal therapy and biological therapy
  • Cervix cancer
  • Concurrent chemo-radiotherapy
  • HDR brachytherapy
  • Uterine cancers
  • Intensity modulated radiotherapy
  • Ovarian cancers
  • Adjuvant and palliative chemotherapy
  • VEGF inhibitors
  • PARP inhibitors
  • Adjuvant breast radiotherapy, palliative chemotherapy for breast cancers
  • Palliative radiotherapy for pain control
  • Endocrine treatment for breast cancers
  • Monoclonal antibody treatment
  • Ovarian cancer
  • Breast radiotherapy

Professional associations

  • Fellow of the Royal College of Radiologists
  • European Society of Gynaecological Oncology
  • European Society of Radiology and Oncology